Back to Authors

Mamelok, Rick

Mayo Clinic

Cellerant Therapeutics (United States)

Citations 1

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.
Abboud, Camille N. , Akard, Luke P., Foran, James M. , Frankfurt, Olga, Hsu, Jack W., Lister, John , Pagel, John M. , Schiller, Gary J. , Solh, Melham, Üstün, Celalettin , Wieduwilt, Matthew J. , Janice, Brown, Wong, Alicia , Kellerman, Lois, Syoc, Rodney Van, Mamelok, Rick, Andreadis, Charalambos Babis , Desai, Pinkal , Gill, Saar , Syoc, Rod Van, Ravandi, Farhad

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7043-7043

10.1200/jco.2018.36.15_suppl.7043 Get It